Physician profile
Ian Cawich
NPI 1427273432
$293,580.44
in general payments reported to CMS, 2019-2025
35 companies · $33K in 2025
The $33K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $26K · 2021: $72K · 2022: $84K · 2023: $7,426 · 2024: $12K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Consulting Fee: $15K · Honoraria: $12K · Travel and Lodging: $6,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,869.72 |
| Consulting Fee | $14,850.00 |
| Honoraria | $12,000.00 |
| Travel and Lodging | $6,421.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $94,320.91 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Crosser Iq |
| Avinger INC. | $68,834.14 | 2019-2023 | Pantheris |
| Cardiovascular Systems INC. | $50,391.80 | 2019-2022 | |
| Shockwave Medical, INC | $29,288.16 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $28,764.29 | 2019-2025 | Cardiomems, Esprit, Accent |
| Asahi Intecc USA, INC. | $12,411.14 | 2023-2025 | Peripheral Vascular, Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires |
| Mercator Medsystems, INC. | $2,818.84 | 2019-2020 | |
| Penumbra, INC. | $1,483.08 | 2023-2025 | Indigo System, Penumbra System |
| Becton, Dickinson and Company | $1,117.83 | 2025 | Rotarexs 6 F X 135 Cm, Lifestream, Venovo |
| Boston Scientific Corporation | $857.73 | 2019-2024 | Eluvia |
| Abiomed | $516.65 | 2019-2024 | Impella |
| Cardiva Medical, INC. | $470.30 | 2021-2023 | Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $440.98 | 2019-2025 | IV Other |
| Avantec Vascular Corporation | $270.40 | 2022-2025 | |
| Terumo Medical Corporation | $240.48 | 2023-2025 | Azur Cx Detachable, Angio-Seal, Metacross Otw |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $239.23 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $194.86 | 2019-2025 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $189.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $102.52 | 2025 | |
| Endologix LLC | $89.03 | 2025 | Endocross Device, Torus Stent Graft System |
| Janssen Pharmaceuticals, INC | $85.62 | 2023-2024 | Xarelto |
| Pfizer INC. | $80.77 | 2024-2025 | |
| Acist Medical Systems, INC. | $77.53 | 2019 | |
| Cordis US Corp. | $41.39 | 2024 | Mynx Control, Rain Sheath |
| Angiodynamics, INC. | $39.43 | 2022 | |
| Thrombolex, INC. | $35.00 | 2025 | Bashir Endovascular Catheter |
| Livanova USA, INC. | $32.96 | 2023 | Lifesparc |
| Reflow Medical INC | $27.40 | 2025 | |
| Stryker Corporation | $23.77 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $23.56 | 2024 | Heli-Fx Endoanchor System |
| Teleflex LLC | $23.17 | 2025 | Titan Sgs Bailout Chuck |
| Glaxosmithkline, LLC. | $18.52 | 2025 | Shingrix |
| Merck Sharp & Dohme LLC | $16.50 | 2021 | |
| Medtronic Vascular, INC. | $12.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Cawich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.